Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021

S. Ewig; M. Kolditz; M. Pletz; A. Altiner; W. Albrich; D. Dromann; H. Flick; S. Gatermann; S. Kroger; W. Nehls; M. Panning; J. Rademacher; G. Rohde; J. Rupp; B. Schaaf; H. J. Heppner; R. Krause; S. Ott; T. Welte; M. Witzenrath

doi:10.1055/a-1383-5737

Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021

Translated title of the contribution: Management of adult community-acquired pneumonia and prevention update 2021

S. Ewig^*, M. Kolditz, M. Pletz, A. Altiner, W. Albrich, D. Dromann, H. Flick, S. Gatermann, S. Kroger, W. Nehls, M. Panning, J. Rademacher, G. Rohde, J. Rupp, B. Schaaf, H. J. Heppner, R. Krause, S. Ott, T. Welte, M. Witzenrath

^*Corresponding author for this work

Abstract

The present guideline provides a new and updated concept of the management of adult patients with community-Acquired pneumonia. It replaces the previous guideline dating from 2016.The guideline was worked out and agreed on following the standards of methodology of a S3-guideline. This includes a systematic literature search and grading, a structured discussion of recommendations supported by the literature as well as the declaration and assessment of potential conflicts of interests. The guideline has a focus on specific clinical circumstances, an update on severity assessment, and includes recommendations for an individualized selection of antimicrobial treatment. The recommendations aim at the same time at a structured assessment of risk for adverse outcome as well as an early determination of treatment goals in order to reduce mortality in patients with curative treatment goal and to provide palliation for patients with treatment restrictions.

Translated title of the contribution	Management of adult community-acquired pneumonia and prevention update 2021
Original language	German
Journal	Pneumologie
ISSN	0934-8387
DOIs	https://doi.org/10.1055/a-1383-5737
Publication status	Accepted/In press - 2021

Access to Document

10.1055/a-1383-5737

Cite this

Ewig, S., Kolditz, M., Pletz, M., Altiner, A., Albrich, W., Dromann, D., Flick, H., Gatermann, S., Kroger, S., Nehls, W., Panning, M., Rademacher, J., Rohde, G., Rupp, J., Schaaf, B., Heppner, H. J., Krause, R., Ott, S., Welte, T., & Witzenrath, M. (Accepted/In press). Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021. Pneumologie. https://doi.org/10.1055/a-1383-5737

@article{da9d36781a0c47318f26bda18af06cbc,

title = "Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021",

abstract = "The present guideline provides a new and updated concept of the management of adult patients with community-Acquired pneumonia. It replaces the previous guideline dating from 2016.The guideline was worked out and agreed on following the standards of methodology of a S3-guideline. This includes a systematic literature search and grading, a structured discussion of recommendations supported by the literature as well as the declaration and assessment of potential conflicts of interests. The guideline has a focus on specific clinical circumstances, an update on severity assessment, and includes recommendations for an individualized selection of antimicrobial treatment. The recommendations aim at the same time at a structured assessment of risk for adverse outcome as well as an early determination of treatment goals in order to reduce mortality in patients with curative treatment goal and to provide palliation for patients with treatment restrictions.",

author = "S. Ewig and M. Kolditz and M. Pletz and A. Altiner and W. Albrich and D. Dromann and H. Flick and S. Gatermann and S. Kroger and W. Nehls and M. Panning and J. Rademacher and G. Rohde and J. Rupp and B. Schaaf and Heppner, {H. J.} and R. Krause and S. Ott and T. Welte and M. Witzenrath",

year = "2021",

doi = "10.1055/a-1383-5737",

language = "Deutsch",

journal = "Pneumologie",

issn = "0934-8387",

}

TY - JOUR

T1 - Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021

AU - Ewig, S.

AU - Kolditz, M.

AU - Pletz, M.

AU - Altiner, A.

AU - Albrich, W.

AU - Dromann, D.

AU - Flick, H.

AU - Gatermann, S.

AU - Kroger, S.

AU - Nehls, W.

AU - Panning, M.

AU - Rademacher, J.

AU - Rohde, G.

AU - Rupp, J.

AU - Schaaf, B.

AU - Heppner, H. J.

AU - Krause, R.

AU - Ott, S.

AU - Welte, T.

AU - Witzenrath, M.

PY - 2021

Y1 - 2021

N2 - The present guideline provides a new and updated concept of the management of adult patients with community-Acquired pneumonia. It replaces the previous guideline dating from 2016.The guideline was worked out and agreed on following the standards of methodology of a S3-guideline. This includes a systematic literature search and grading, a structured discussion of recommendations supported by the literature as well as the declaration and assessment of potential conflicts of interests. The guideline has a focus on specific clinical circumstances, an update on severity assessment, and includes recommendations for an individualized selection of antimicrobial treatment. The recommendations aim at the same time at a structured assessment of risk for adverse outcome as well as an early determination of treatment goals in order to reduce mortality in patients with curative treatment goal and to provide palliation for patients with treatment restrictions.

AB - The present guideline provides a new and updated concept of the management of adult patients with community-Acquired pneumonia. It replaces the previous guideline dating from 2016.The guideline was worked out and agreed on following the standards of methodology of a S3-guideline. This includes a systematic literature search and grading, a structured discussion of recommendations supported by the literature as well as the declaration and assessment of potential conflicts of interests. The guideline has a focus on specific clinical circumstances, an update on severity assessment, and includes recommendations for an individualized selection of antimicrobial treatment. The recommendations aim at the same time at a structured assessment of risk for adverse outcome as well as an early determination of treatment goals in order to reduce mortality in patients with curative treatment goal and to provide palliation for patients with treatment restrictions.

UR - http://www.scopus.com/inward/record.url?scp=85110156104&partnerID=8YFLogxK

U2 - 10.1055/a-1383-5737

DO - 10.1055/a-1383-5737

M3 - Übersichtsarbeiten

AN - SCOPUS:85110156104

SN - 0934-8387

JO - Pneumologie

JF - Pneumologie

ER -

Behandlung von erwachsenen patientenmit ambulant erworbener pneumonie update 2021

Abstract

Access to Document

Other files and links

Fingerprint

Cite this